| 1227P Novel in vivo photonics-immunoassay system, inPROBE, for the rapid detection of HER2 in breast cancer M Staniszewska, A Kurylcio, K Sędłak, WP Polkowski, M Śmietana, ... Annals of Oncology 34, S718, 2023 | | 2023 |
| A propensity score matched analysis of superparamagnetic iron oxide versus radioisotope sentinel node biopsy in breast cancer patients after neoadjuvant chemotherapy Z Pelc, M Skórzewska, M Kurylcio, T Nowikiewicz, R Mlak, K Sędłak, ... Cancers 14 (3), 676, 2022 | 7 | 2022 |
| ASO Visual Abstract: Neoadjuvant Chemotherapy Improves Oncologic Outcomes and Long-Term Survival for Elderly Patients with Locally Advanced Gastric Cancer: A Propensity Score … K Rawicz-Pruszyński, Y Endo, DI Tsilimigras, MM Munir, V Resende, ... Annals of surgical oncology 31 (3), 1796-1797, 2024 | | 2024 |
| Author Correction: Prognostic value of molecular cytology by one‑step nucleic acid amplifcation (OSNA) assay of peritoneal washings in advanced gastric cancer patients K Gęca, M Skórzewska, K Rawicz‑Pruszyński, R Mlak, K Sędłak, Z Pelc, ... Scientific Reports 13, 2023 | | 2023 |
| Better Safe than Sorry: Prevention of Esophagojejunostomy Leak by Intraoperative Methylene Blue Test in Advanced Gastric Cancer K Sędłak, K Rawicz-Pruszyński, R Mlak, J Mielko, K Gęca, WP Polkowski Journal of Gastrointestinal Surgery 25 (9), 2401-2403, 2021 | | 2021 |
| Conversion surgery with HIPEC for peritoneal oli-gometastatic gastric cancer J Mielko, K Rawicz-Pruszyński, M Skórzewska, B Ciseł, A Pikuła, ... Cancers 11 (11), 1715, 2019 | 19 | 2019 |
| Current Status of Treatment among Patients with Appendiceal Tumors—Old Challenges and New Solutions? K Chawrylak, M Leśniewska, K Mielniczek, K Sędłak, Z Pelc, S Kobiałka, ... Cancers 16 (5), 866, 2024 | | 2024 |
| Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies: learning curve based on surgical and oncological outcomes J Mielko, K Rawicz-Pruszyński, K Sędłak, K Gęca, M Kwietniewska, ... Cancers 12 (9), 2387, 2020 | 5 | 2020 |
| Evaluation of optimum classification measures used to define textbook outcome among patients undergoing curative-intent resection of gastric cancer L Bobrzynski, K Sędłak, K Rawicz-Pruszyński, P Kolodziejczyk, ... BMC cancer 23 (1), 1199, 2023 | 1 | 2023 |
| Gut Microbiota—Adversary or Ally? Its Role and Significance in Colorectal Cancer Pathogenesis, Progression, and Treatment K Chawrylak, M Leśniewska, K Mielniczek, K Sędłak, Z Pelc, TM Pawlik, ... Cancers 16 (12), 2236, 2024 | | 2024 |
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC), Oncological Outcomes and Long-Term Survival among Patients with Gastric Cancer and Limited Peritoneal Disease Progression … S Kobiałka, K Sędłak, Z Pelc, R Mlak, Y Endo, P Bogacz, A Kurylcio, ... Journal of Clinical Medicine 13 (1), 161, 2023 | 1 | 2023 |
| International Journal of Surgery Publish Ahead of Print K Rawicz-Pruszyński, M Erodotou, Z Pelc, K Sędłak, W Polkowski, ... | | 2023 |
| Katarzyna Gęca, Magdalena Skórzewska, Karol Rawicz‑Pruszyński, Radosław Mlak K Sędłak, Z Pelc, T Małecka‑Massalska, WP Polkowski Scientific Reports 13, 1533, 2023 | | 2023 |
| MalnutritiOn assessment with biOelectrical impedaNce analysis in gastRic cancer patIentS undergoing multimodaltrEatment (MOONRISE)—Study protocol for a single-arm multicenter … Z Pelc, K Sędłak, R Mlak, K Chawrylak, K Mielniczek, M Leśniewska, ... Plos one 19 (2), e0297583, 2024 | | 2024 |
| Mixed type histology as a predictive factor for esophagojejunostomy leak in advanced gastric cancer K Rawicz-Pruszyński, K Sędłak, R Mlak, J Mielko, WP Polkowski Cancers 12 (6), 1701, 2020 | 4 | 2020 |
| Molecular cytology by One-Step Nucleic Acid Amplification (OSNA) assay of peritoneal washings during D2 gastrectomy in advanced gastric cancer patients: preliminary results K Gęca, K Rawicz-Pruszyński, R Mlak, K Sędłak, M Skórzewska, Z Pelc, ... Journal of Clinical Medicine 10 (22), 5230, 2021 | 2 | 2021 |
| Neoadjuvant chemotherapy improves oncological outcomes and long-term survival among elderly patients with locally advanced gastric cancer: a propensity score matched analysis K Rawicz-Pruszyński, Y Endo, DI Tsilimigras, MM Munir, V Resende, ... Annals of Surgical Oncology 31 (2), 753-761, 2024 | 1 | 2024 |
| Prognostic Value of Inflammatory Burden Index in Advanced Gastric Cancer Patients Undergoing Multimodal Treatment Z Pelc, K Sędłak, R Mlak, M Leśniewska, K Mielniczek, P Rola, ... Cancers 16 (4), 828, 2024 | 1 | 2024 |
| Prognostic value of molecular cytology by one-step nucleic acid amplification (OSNA) assay of peritoneal washings in advanced gastric cancer patients K Gęca, M Skórzewska, K Rawicz-Pruszyński, R Mlak, K Sędłak, Z Pelc, ... Scientific reports 12 (1), 12477, 2022 | 1 | 2022 |
| Prognostic value of systemic inflammatory response markers in patients undergoing neoadjuvant chemotherapy and gastrectomy for advanced gastric cancer in the eastern European … A Pikuła, M Skórzewska, Z Pelc, R Mlak, K Gęca, K Sędłak, B Ciseł, ... Cancers 14 (8), 1997, 2022 | 12 | 2022 |
Karol Rawicz-PruszyńskiDepartment of Surgical Oncology, Medical University of Lublin在 uml.edu.pl 的电子邮件经过验证
